TrialInternal and emergency medicine2024

Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials.

Maddalena Alessandra Wu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.